aluates Reports

$ 0.0

Automative

Global Valganciclovir API Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-3N11864

Global Valganciclovir API Market Research Report 2022

BUY CHAPTERS

Global Valganciclovir API Market Research Report 2025

Code: QYRE-Auto-3N11864

Report

February 2025

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Mylan NV

Extrovis AG

Aurore Life Sciences

Hetero Drugs

DEAFARMA

Rakshit Drugs

Anthem Biosciences

Hanways Chempharm Co., Limited

Calyx Chemicals & Pharmaceuticals Limited

Biophore India Pharmaceuticals Pvt. Ltd.

Aspire Lifesciences Pvt Ltd

Valganciclovir API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Valganciclovir API Market

The global market for Valganciclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Valganciclovir(CAS：175865-60-8) also called Valgancyclovir,is an antiviral medication used to treat cytomegalovirus (CMV) infection in those with HIV/AIDS or following organ transplant.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Valganciclovir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valganciclovir API.

The Valganciclovir API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Valganciclovir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Valganciclovir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Valganciclovir API Market Report

Report Metric	Details
Report Name	Valganciclovir API Market
CAGR	5%
by Type	Above 98 % Above 99 %
by Application	Tablets Oral Solution Others
Production by Region	North America Europe China India
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biophore India Pharmaceuticals Pvt Ltd, Mylan, Extrovis AG, Aurore Life Sciences, Hetero Drugs, Calyx Chemicals & Pharmaceuticals Limited, DEAFARMA, Aspire Lifesciences Pvt Ltd, Rakshit Drugs, Anthem Biosciences, Hanways Chempharm Co., Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valganciclovir API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Valganciclovir API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Valganciclovir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Valganciclovir API Market report?

Ans: The main players in the Valganciclovir API Market are Biophore India Pharmaceuticals Pvt Ltd, Mylan, Extrovis AG, Aurore Life Sciences, Hetero Drugs, Calyx Chemicals & Pharmaceuticals Limited, DEAFARMA, Aspire Lifesciences Pvt Ltd, Rakshit Drugs, Anthem Biosciences, Hanways Chempharm Co., Limited

What are the Application segmentation covered in the Valganciclovir API Market report?

Ans: The Applications covered in the Valganciclovir API Market report are Tablets, Oral Solution, Others

What are the Type segmentation covered in the Valganciclovir API Market report?

Ans: The Types covered in the Valganciclovir API Market report are Above 98 %, Above 99 %

1 Valganciclovir API Market Overview

1.1 Product Definition

1.2 Valganciclovir API by Type

1.2.1 Global Valganciclovir API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Above 98 %

1.2.3 Above 99 %

1.3 Valganciclovir API by Application

1.3.1 Global Valganciclovir API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Tablets

1.3.3 Oral Solution

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Valganciclovir API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Valganciclovir API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Valganciclovir API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Valganciclovir API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Valganciclovir API Production Market Share by Manufacturers (2020-2025)

2.2 Global Valganciclovir API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Valganciclovir API, Industry Ranking, 2023 VS 2024

2.4 Global Valganciclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Valganciclovir API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Valganciclovir API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Valganciclovir API, Product Offered and Application

2.8 Global Key Manufacturers of Valganciclovir API, Date of Enter into This Industry

2.9 Valganciclovir API Market Competitive Situation and Trends

2.9.1 Valganciclovir API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Valganciclovir API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Valganciclovir API Production by Region

3.1 Global Valganciclovir API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Valganciclovir API Production Value by Region (2020-2031)

3.2.1 Global Valganciclovir API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Valganciclovir API by Region (2026-2031)

3.3 Global Valganciclovir API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Valganciclovir API Production Volume by Region (2020-2031)

3.4.1 Global Valganciclovir API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Valganciclovir API by Region (2026-2031)

3.5 Global Valganciclovir API Market Price Analysis by Region (2020-2025)

3.6 Global Valganciclovir API Production and Value, Year-over-Year Growth

3.6.1 North America Valganciclovir API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Valganciclovir API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Valganciclovir API Production Value Estimates and Forecasts (2020-2031)

3.6.4 India Valganciclovir API Production Value Estimates and Forecasts (2020-2031)

4 Valganciclovir API Consumption by Region

4.1 Global Valganciclovir API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Valganciclovir API Consumption by Region (2020-2031)

4.2.1 Global Valganciclovir API Consumption by Region (2020-2025)

4.2.2 Global Valganciclovir API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Valganciclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Valganciclovir API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Valganciclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Valganciclovir API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Valganciclovir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Valganciclovir API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Valganciclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Valganciclovir API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Valganciclovir API Production by Type (2020-2031)

5.1.1 Global Valganciclovir API Production by Type (2020-2025)

5.1.2 Global Valganciclovir API Production by Type (2026-2031)

5.1.3 Global Valganciclovir API Production Market Share by Type (2020-2031)

5.2 Global Valganciclovir API Production Value by Type (2020-2031)

5.2.1 Global Valganciclovir API Production Value by Type (2020-2025)

5.2.2 Global Valganciclovir API Production Value by Type (2026-2031)

5.2.3 Global Valganciclovir API Production Value Market Share by Type (2020-2031)

5.3 Global Valganciclovir API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Valganciclovir API Production by Application (2020-2031)

6.1.1 Global Valganciclovir API Production by Application (2020-2025)

6.1.2 Global Valganciclovir API Production by Application (2026-2031)

6.1.3 Global Valganciclovir API Production Market Share by Application (2020-2031)

6.2 Global Valganciclovir API Production Value by Application (2020-2031)

6.2.1 Global Valganciclovir API Production Value by Application (2020-2025)

6.2.2 Global Valganciclovir API Production Value by Application (2026-2031)

6.2.3 Global Valganciclovir API Production Value Market Share by Application (2020-2031)

6.3 Global Valganciclovir API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Biophore India Pharmaceuticals Pvt Ltd

7.1.1 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Company Information

7.1.2 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Product Portfolio

7.1.3 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Biophore India Pharmaceuticals Pvt Ltd Main Business and Markets Served

7.1.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates

7.2 Mylan

7.2.1 Mylan Valganciclovir API Company Information

7.2.2 Mylan Valganciclovir API Product Portfolio

7.2.3 Mylan Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Mylan Main Business and Markets Served

7.2.5 Mylan Recent Developments/Updates

7.3 Extrovis AG

7.3.1 Extrovis AG Valganciclovir API Company Information

7.3.2 Extrovis AG Valganciclovir API Product Portfolio

7.3.3 Extrovis AG Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Extrovis AG Main Business and Markets Served

7.3.5 Extrovis AG Recent Developments/Updates

7.4 Aurore Life Sciences

7.4.1 Aurore Life Sciences Valganciclovir API Company Information

7.4.2 Aurore Life Sciences Valganciclovir API Product Portfolio

7.4.3 Aurore Life Sciences Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Aurore Life Sciences Main Business and Markets Served

7.4.5 Aurore Life Sciences Recent Developments/Updates

7.5 Hetero Drugs

7.5.1 Hetero Drugs Valganciclovir API Company Information

7.5.2 Hetero Drugs Valganciclovir API Product Portfolio

7.5.3 Hetero Drugs Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Hetero Drugs Main Business and Markets Served

7.5.5 Hetero Drugs Recent Developments/Updates

7.6 Calyx Chemicals & Pharmaceuticals Limited

7.6.1 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Company Information

7.6.2 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Product Portfolio

7.6.3 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Calyx Chemicals & Pharmaceuticals Limited Main Business and Markets Served

7.6.5 Calyx Chemicals & Pharmaceuticals Limited Recent Developments/Updates

7.7 DEAFARMA

7.7.1 DEAFARMA Valganciclovir API Company Information

7.7.2 DEAFARMA Valganciclovir API Product Portfolio

7.7.3 DEAFARMA Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 DEAFARMA Main Business and Markets Served

7.7.5 DEAFARMA Recent Developments/Updates

7.8 Aspire Lifesciences Pvt Ltd

7.8.1 Aspire Lifesciences Pvt Ltd Valganciclovir API Company Information

7.8.2 Aspire Lifesciences Pvt Ltd Valganciclovir API Product Portfolio

7.8.3 Aspire Lifesciences Pvt Ltd Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Aspire Lifesciences Pvt Ltd Main Business and Markets Served

7.8.5 Aspire Lifesciences Pvt Ltd Recent Developments/Updates

7.9 Rakshit Drugs

7.9.1 Rakshit Drugs Valganciclovir API Company Information

7.9.2 Rakshit Drugs Valganciclovir API Product Portfolio

7.9.3 Rakshit Drugs Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Rakshit Drugs Main Business and Markets Served

7.9.5 Rakshit Drugs Recent Developments/Updates

7.10 Anthem Biosciences

7.10.1 Anthem Biosciences Valganciclovir API Company Information

7.10.2 Anthem Biosciences Valganciclovir API Product Portfolio

7.10.3 Anthem Biosciences Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Anthem Biosciences Main Business and Markets Served

7.10.5 Anthem Biosciences Recent Developments/Updates

7.11 Hanways Chempharm Co., Limited

7.11.1 Hanways Chempharm Co., Limited Valganciclovir API Company Information

7.11.2 Hanways Chempharm Co., Limited Valganciclovir API Product Portfolio

7.11.3 Hanways Chempharm Co., Limited Valganciclovir API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Hanways Chempharm Co., Limited Main Business and Markets Served

7.11.5 Hanways Chempharm Co., Limited Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Valganciclovir API Industry Chain Analysis

8.2 Valganciclovir API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Valganciclovir API Production Mode & Process Analysis

8.4 Valganciclovir API Sales and Marketing

8.4.1 Valganciclovir API Sales Channels

8.4.2 Valganciclovir API Distributors

8.5 Valganciclovir API Customer Analysis

9 Valganciclovir API Market Dynamics

9.1 Valganciclovir API Industry Trends

9.2 Valganciclovir API Market Drivers

9.3 Valganciclovir API Market Challenges

9.4 Valganciclovir API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Mylan NV

Extrovis AG

Aurore Life Sciences

Hetero Drugs

DEAFARMA

Rakshit Drugs

Anthem Biosciences

Hanways Chempharm Co., Limited

Calyx Chemicals & Pharmaceuticals Limited

Biophore India Pharmaceuticals Pvt. Ltd.

Aspire Lifesciences Pvt Ltd

List of Tables

Table 1. Global Valganciclovir API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Valganciclovir API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Valganciclovir API Production Capacity (Kg) by Manufacturers in 2024

Table 4. Global Valganciclovir API Production by Manufacturers (2020-2025) & (Kg)

Table 5. Global Valganciclovir API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Valganciclovir API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Valganciclovir API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Valganciclovir API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Valganciclovir API as of 2024)

Table 10. Global Market Valganciclovir API Average Price by Manufacturers (US$/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of Valganciclovir API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Valganciclovir API, Product Offered and Application

Table 13. Global Key Manufacturers of Valganciclovir API, Date of Enter into This Industry

Table 14. Global Valganciclovir API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Valganciclovir API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Valganciclovir API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Valganciclovir API Production Value Market Share by Region (2020-2025)

Table 19. Global Valganciclovir API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Valganciclovir API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Valganciclovir API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Valganciclovir API Production (Kg) by Region (2020-2025)

Table 23. Global Valganciclovir API Production Market Share by Region (2020-2025)

Table 24. Global Valganciclovir API Production (Kg) Forecast by Region (2026-2031)

Table 25. Global Valganciclovir API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Valganciclovir API Market Average Price (US$/Kg) by Region (2020-2025)

Table 27. Global Valganciclovir API Market Average Price (US$/Kg) by Region (2026-2031)

Table 28. Global Valganciclovir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 29. Global Valganciclovir API Consumption by Region (2020-2025) & (Kg)

Table 30. Global Valganciclovir API Consumption Market Share by Region (2020-2025)

Table 31. Global Valganciclovir API Forecasted Consumption by Region (2026-2031) & (Kg)

Table 32. Global Valganciclovir API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Valganciclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 34. North America Valganciclovir API Consumption by Country (2020-2025) & (Kg)

Table 35. North America Valganciclovir API Consumption by Country (2026-2031) & (Kg)

Table 36. Europe Valganciclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 37. Europe Valganciclovir API Consumption by Country (2020-2025) & (Kg)

Table 38. Europe Valganciclovir API Consumption by Country (2026-2031) & (Kg)

Table 39. Asia Pacific Valganciclovir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 40. Asia Pacific Valganciclovir API Consumption by Region (2020-2025) & (Kg)

Table 41. Asia Pacific Valganciclovir API Consumption by Region (2026-2031) & (Kg)

Table 42. Latin America, Middle East & Africa Valganciclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 43. Latin America, Middle East & Africa Valganciclovir API Consumption by Country (2020-2025) & (Kg)

Table 44. Latin America, Middle East & Africa Valganciclovir API Consumption by Country (2026-2031) & (Kg)

Table 45. Global Valganciclovir API Production (Kg) by Type (2020-2025)

Table 46. Global Valganciclovir API Production (Kg) by Type (2026-2031)

Table 47. Global Valganciclovir API Production Market Share by Type (2020-2025)

Table 48. Global Valganciclovir API Production Market Share by Type (2026-2031)

Table 49. Global Valganciclovir API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Valganciclovir API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Valganciclovir API Production Value Market Share by Type (2020-2025)

Table 52. Global Valganciclovir API Production Value Market Share by Type (2026-2031)

Table 53. Global Valganciclovir API Price (US$/Kg) by Type (2020-2025)

Table 54. Global Valganciclovir API Price (US$/Kg) by Type (2026-2031)

Table 55. Global Valganciclovir API Production (Kg) by Application (2020-2025)

Table 56. Global Valganciclovir API Production (Kg) by Application (2026-2031)

Table 57. Global Valganciclovir API Production Market Share by Application (2020-2025)

Table 58. Global Valganciclovir API Production Market Share by Application (2026-2031)

Table 59. Global Valganciclovir API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Valganciclovir API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Valganciclovir API Production Value Market Share by Application (2020-2025)

Table 62. Global Valganciclovir API Production Value Market Share by Application (2026-2031)

Table 63. Global Valganciclovir API Price (US$/Kg) by Application (2020-2025)

Table 64. Global Valganciclovir API Price (US$/Kg) by Application (2026-2031)

Table 65. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Company Information

Table 66. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Specification and Application

Table 67. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 68. Biophore India Pharmaceuticals Pvt Ltd Main Business and Markets Served

Table 69. Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates

Table 70. Mylan Valganciclovir API Company Information

Table 71. Mylan Valganciclovir API Specification and Application

Table 72. Mylan Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Mylan Main Business and Markets Served

Table 74. Mylan Recent Developments/Updates

Table 75. Extrovis AG Valganciclovir API Company Information

Table 76. Extrovis AG Valganciclovir API Specification and Application

Table 77. Extrovis AG Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Extrovis AG Main Business and Markets Served

Table 79. Extrovis AG Recent Developments/Updates

Table 80. Aurore Life Sciences Valganciclovir API Company Information

Table 81. Aurore Life Sciences Valganciclovir API Specification and Application

Table 82. Aurore Life Sciences Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Aurore Life Sciences Main Business and Markets Served

Table 84. Aurore Life Sciences Recent Developments/Updates

Table 85. Hetero Drugs Valganciclovir API Company Information

Table 86. Hetero Drugs Valganciclovir API Specification and Application

Table 87. Hetero Drugs Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. Hetero Drugs Main Business and Markets Served

Table 89. Hetero Drugs Recent Developments/Updates

Table 90. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Company Information

Table 91. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Specification and Application

Table 92. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Calyx Chemicals & Pharmaceuticals Limited Main Business and Markets Served

Table 94. Calyx Chemicals & Pharmaceuticals Limited Recent Developments/Updates

Table 95. DEAFARMA Valganciclovir API Company Information

Table 96. DEAFARMA Valganciclovir API Specification and Application

Table 97. DEAFARMA Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. DEAFARMA Main Business and Markets Served

Table 99. DEAFARMA Recent Developments/Updates

Table 100. Aspire Lifesciences Pvt Ltd Valganciclovir API Company Information

Table 101. Aspire Lifesciences Pvt Ltd Valganciclovir API Specification and Application

Table 102. Aspire Lifesciences Pvt Ltd Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Aspire Lifesciences Pvt Ltd Main Business and Markets Served

Table 104. Aspire Lifesciences Pvt Ltd Recent Developments/Updates

Table 105. Rakshit Drugs Valganciclovir API Company Information

Table 106. Rakshit Drugs Valganciclovir API Specification and Application

Table 107. Rakshit Drugs Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Rakshit Drugs Main Business and Markets Served

Table 109. Rakshit Drugs Recent Developments/Updates

Table 110. Anthem Biosciences Valganciclovir API Company Information

Table 111. Anthem Biosciences Valganciclovir API Specification and Application

Table 112. Anthem Biosciences Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. Anthem Biosciences Main Business and Markets Served

Table 114. Anthem Biosciences Recent Developments/Updates

Table 115. Hanways Chempharm Co., Limited Valganciclovir API Company Information

Table 116. Hanways Chempharm Co., Limited Valganciclovir API Specification and Application

Table 117. Hanways Chempharm Co., Limited Valganciclovir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Hanways Chempharm Co., Limited Main Business and Markets Served

Table 119. Hanways Chempharm Co., Limited Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Valganciclovir API Distributors List

Table 123. Valganciclovir API Customers List

Table 124. Valganciclovir API Market Trends

Table 125. Valganciclovir API Market Drivers

Table 126. Valganciclovir API Market Challenges

Table 127. Valganciclovir API Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Valganciclovir API

Figure 2. Global Valganciclovir API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Valganciclovir API Market Share by Type: 2024 VS 2031

Figure 4. Above 98 % Product Picture

Figure 5. Above 99 % Product Picture

Figure 6. Global Valganciclovir API Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Valganciclovir API Market Share by Application: 2024 VS 2031

Figure 8. Tablets

Figure 9. Oral Solution

Figure 10. Others

Figure 11. Global Valganciclovir API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Valganciclovir API Production Value (US$ Million) & (2020-2031)

Figure 13. Global Valganciclovir API Production Capacity (Kg) & (2020-2031)

Figure 14. Global Valganciclovir API Production (Kg) & (2020-2031)

Figure 15. Global Valganciclovir API Average Price (US$/Kg) & (2020-2031)

Figure 16. Valganciclovir API Report Years Considered

Figure 17. Valganciclovir API Production Share by Manufacturers in 2024

Figure 18. Global Valganciclovir API Production Value Share by Manufacturers (2024)

Figure 19. Valganciclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Valganciclovir API Revenue in 2024

Figure 21. Global Valganciclovir API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Valganciclovir API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Valganciclovir API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 24. Global Valganciclovir API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Valganciclovir API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Valganciclovir API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Valganciclovir API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. India Valganciclovir API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Global Valganciclovir API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 30. Global Valganciclovir API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 31. North America Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 32. North America Valganciclovir API Consumption Market Share by Country (2020-2031)

Figure 33. U.S. Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 34. Canada Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 35. Europe Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 36. Europe Valganciclovir API Consumption Market Share by Country (2020-2031)

Figure 37. Germany Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 38. France Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 39. U.K. Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 40. Italy Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 41. Russia Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 42. Asia Pacific Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 43. Asia Pacific Valganciclovir API Consumption Market Share by Region (2020-2031)

Figure 44. China Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 45. Japan Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 46. South Korea Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 47. China Taiwan Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 48. Southeast Asia Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 49. India Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 50. Latin America, Middle East & Africa Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 51. Latin America, Middle East & Africa Valganciclovir API Consumption Market Share by Country (2020-2031)

Figure 52. Mexico Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 53. Brazil Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 54. Turkey Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 55. GCC Countries Valganciclovir API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 56. Global Production Market Share of Valganciclovir API by Type (2020-2031)

Figure 57. Global Production Value Market Share of Valganciclovir API by Type (2020-2031)

Figure 58. Global Valganciclovir API Price (US$/Kg) by Type (2020-2031)

Figure 59. Global Production Market Share of Valganciclovir API by Application (2020-2031)

Figure 60. Global Production Value Market Share of Valganciclovir API by Application (2020-2031)

Figure 61. Global Valganciclovir API Price (US$/Kg) by Application (2020-2031)

Figure 62. Valganciclovir API Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Valganciclovir Market Insights Forecast to 2030

Global Valganciclovir Tablets Market Research Report 2024

Global Valacyclovir API Market Research Report 2025

Global Valacyclovir Hcl API Market Research Report 2025

Global Cytomegalovirus HHV 5 Infection Therapeutic Drugs Market Insights Forecast to 2030

Global Letermovir API Market Research Report 2024

Global Cytomegalovirus Treatment Market Research Report 2024

Global Cytomegalovirus Disease Treatments Market Research Report 2024

Global Cytomegalovirus CMV Treatment Drugs Market Research Report 2024

Cytomegalovirus Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Aciclovir Market Research Report 2024

Global Valacyclovir Hydrochloride Market Research Report 2025

Global Valacyclovir Market Research Report 2024

Global Cytomegalovirus Retinitis Treatment Market Research Report 2024

Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Research Report 2024

Global Efavirenz API Market Research Report 2025

Global Acyclovir API Market Research Report 2025

Global Raltegravir API Market Research Report 2025

Global Cytomegalovirus Assay Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions